Project Details
Projekt Print View

The Role of Macrophage Migration Inhibitory Factor (MIF) Family Proteins in Wound Repair and Obesity

Subject Area General and Visceral Surgery
Term from 2018 to 2023
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 394654802
 
Final Report Year 2024

Final Report Abstract

Cutaneous wound healing is a complex physiological process, in which a damage to the skin is restored. While healing of minor wounds in healthy individuals is of little concern in most cases, complex wounds with exposure of important structures or wounds in patients with underlying diseases can be threatening. In recent years, a drastic increase of obesity, which also is a known risk factor for type 2 diabetes mellitus, was observed troubling healthcare professionals globally. Wound healing, obesity and diabetes are closely intertwined but the underlying factors and mechanisms are not yet fully understood. It is believed that adipose tissue underlies a state of chronic inflammation in obese subjects, which in turn alters glucose metabolism and wound healing. A group of proteins that may play an important role in this context is the macrophage migration inhibitory factor, in short MIF, family. Its first discovered member, MIF or MIF-1, is a long-known pro-inflammatory protein whereas its recently discovered sister protein MIF-2 appears to have a more ambivalent role in inflammation. Previous preliminary results indicated that MIF-2 in particular may counteract adipose tissue inflammation and improve cutaneous wound healing, while MIF-1 acts in an opposing way. In the present project, a closer look on both proteins in cutaneous wound healing, obesity and adipose tissue inflammation was taken and ways for clinical translation were explored. The research was done in a collaboration between basic scientists and clinicians to provide a most comprehensive view on this complex but clinically relevant topic.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung